Drug companies warn of rocky IPR road ahead
Domestic drug companies have sounded a note of caution on the hassles that could surface in the details of the legal framework that is being laid out for the product-patent regime, come January 2005.
Domestic drug companies have sounded a note of caution on the hassles that could surface in the details of the legal framework that is being laid out for the product-patent regime, come January 2005.